Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program
Kathryn Bieging-Rolett, Alyssa M. Kaiser, David W. Morgens, et al.
Molecular Cell (2020) Vol. 80, Iss. 3, pp. 452-469.e9
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

p53 and Tumor Suppression: It Takes a Network
Anthony M. Boutelle, Laura D. Attardi
Trends in Cell Biology (2021) Vol. 31, Iss. 4, pp. 298-310
Open Access | Times Cited: 236
Understanding the complexity of p53 in a new era of tumor suppression
Yanqing Liu, Zhenyi Su, Omid Tavana, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 946-967
Open Access | Times Cited: 102
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Annabella F. Thomas, Gemma L. Kelly, Andreas Strasser
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 961-971
Open Access | Times Cited: 77
The Mettl3 epitranscriptomic writer amplifies p53 stress responses
Nitin Raj, Mengxiong Wang, José A. Seoane, et al.
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2370-2384.e10
Open Access | Times Cited: 47
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells
Yichao Hou, Xintian Zhang, Han Yao, et al.
EMBO Reports (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 41
The microRNA cluster C19MC confers differentiation potential into trophoblast lineages upon human pluripotent stem cells
Norio Kobayashi, Hiroaki Okae, Hitoshi Hiura, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yufang Bao, Sirui Zhang, Xiaoyu Zhang, et al.
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1490-1502
Open Access | Times Cited: 23
The Art of Finding the Right Drug Target: Emerging Methods and Strategies
Zi-Chang Jia, Xue Yang, Yikun Wu, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 896-914
Open Access | Times Cited: 13
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression
Alexandra Indeglia, Maureen E. Murphy
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 128-138
Open Access | Times Cited: 9
SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage
Karla F. Meza‐Sosa, Rui Miao, Francisco Navarro, et al.
Molecular Cell (2022) Vol. 82, Iss. 4, pp. 785-802.e10
Open Access | Times Cited: 37
RNA-binding proteins: Underestimated contributors in tumorigenesis
Yubo Zhao, Cristina Mir, Yoelsis García-Mayea, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 431-444
Closed Access | Times Cited: 32
RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4
H Weinstein, Kevin Hu, Lisa Fish, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114622-114622
Open Access | Times Cited: 6
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Mengxiong Wang, Laura D. Attardi
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 205-226
Open Access | Times Cited: 35
Understanding p53 tumour suppressor network
Emanuele Panatta, Carlotta Zampieri, Gerry Melino, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 34
ZMAT3 hypomethylation contributes to early senescence of preadipocytes from healthy first‐degree relatives of type 2 diabetics
Rosa Spinelli, Pasqualina Florese, Luca Parrillo, et al.
Aging Cell (2022) Vol. 21, Iss. 3
Open Access | Times Cited: 27
p53 promotes peroxisomal fatty acid β-oxidation to repress purine biosynthesis and mediate tumor suppression
Jianhong Zhao, Xiaojun Zhou, Baoxiang Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 13
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
Jinyue Yan, Diana D. Kang, Gillian Turnbull, et al.
Advanced Drug Delivery Reviews (2021) Vol. 180, pp. 114042-114042
Open Access | Times Cited: 31
CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
Long Jiang, Katrine Ingelshed, Yunbing Shen, et al.
Cancer Research (2021) Vol. 82, Iss. 1, pp. 36-45
Open Access | Times Cited: 30
ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway
Zuyi Ma, Zhenchong Li, Shujie Wang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 21
PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis
Keerthana Gnanapradeepan, Alexandra Indeglia, David C. Stieg, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102637-102637
Open Access | Times Cited: 21
An African-Specific Variant ofTP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression
Alexandra Indeglia, Jessica C. Leung, Sven A. Miller, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1696-1719
Open Access | Times Cited: 12
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression
Yaxuan Zhou, Rinka Nakajima, Mashiro Shirasawa, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1511-1511
Open Access | Times Cited: 12
The ribosomal protein L22 binds the MDM4 pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress
Jennifer Jansen, Katherine E. Bohnsack, Susanne Böhlken-Fascher, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114610-114610
Open Access | Times Cited: 4
FN1 shapes the behavior of papillary thyroid carcinoma through alternative splicing of EDB region
Mian Liu, Pei Chen, Bo Wei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation
Jana Key, Luis E. Almaguer-Mederos, Arvind Reddy Kandi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Page 1 - Next Page

Scroll to top